Personalised medicine promotes the health and wellbeing of individuals by utilising research, new technologies and wider information resources. The aim is to prevent diseases and to improve diagnostics and the effectiveness of treatments. At the same time, privacy protection will be ensured and people's opportunities to influence their own health will be supported.
The objective is that by 2020, the operating models and funding for a genome centre, a national cancer centre, a national neurocentre, and a cooperative that coordinates the operation of biobanks will be well established in Finland. These centres will help implement the Health Sector Growth Strategy and strengthen national research, development, and innovation activities and safeguards the equality and high quality of treatment in future Finland.
Strong national coordination and joint operators are a prerequisite for the full utilisation of healthcare data reserves, biobanks’ sample collections and the new genomic data.
Read more about the Health Sector Growth Strategy